Sign in
Groups
Researchers
Results
HOSPITAL UNIVERSITARIO RUBER
Department
Humboldt University of Berlin
Berlín, Alemania
You are in
Collaborations
Humboldt University of Berlin
Publications in collaboration with researchers from Humboldt University of Berlin (1)
2019
Three-year follow-up from a phase 3 study of SB3 (a trastuzumab biosimilar) versus reference trastuzumab in the neoadjuvant setting for human epidermal growth factor receptor 2–positive breast cancer
European Journal of Cancer, Vol. 120, pp. 1-9
Contact
Legal notice
Help
translate
en
arrow_drop_down
translate
en
arrow_drop_down
es
ca
eu
gl
fr
de